Teva Pharmaceutical Industries reported $7.98B in Equity Capital and Reserves for its fiscal quarter ending in September of 2026.





Equity Capital And Reserves Change Date
Aspen Pharmacare ZAR 80.37B 717M Jun/2026
Cipla INR 353.96B 9.64B Sep/2026
Dr.Reddys Laboratories INR 388.07B 1.34B Sep/2026
Guangzhou Baiy CNY 39.04B 1.18B Sep/2026
Jiangsu Hengrui CNY 66.81B 2.35B Sep/2026
Kalbe Farma IDR 25.11T 655.04B Sep/2026
Richter Gedeon HUF 1.36T 98.28B Jun/2026
Sh Fosun Pharma CNY 50.3B 961.4M Sep/2026
Sun Pharmaceuticals INR 892.8B 57.1B Sep/2026
Teva Pharmaceutical Industries USD 7.98B 226M Sep/2026